Associated Papers
The CYP3A4*22 C>T single nucleotide polymorphism is associated with reduced midazolam and tacrolimus clearance in stable renal allograft recipients.
de Jonge H et al.
The Pharmacogenomics Journal, 2015
In vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients.
de Jonge H et al.
Clinical Pharmacology and Therapeutics, 2012
Select a paper to view details